Online citations, reference lists, and bibliographies.
← Back to Search

Luminal-type Breast Cancer: Correlation Of Apparent Diffusion Coefficients With The Ki-67 Labeling Index.

Naoko Mori, H. Ota, S. Mugikura, Chiaki Takasawa, T. Ishida, Gou Watanabe, H. Tada, M. Watanabe, Kei Takase, S. Takahashi
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
PURPOSE To evaluate the correlation between apparent diffusion coefficient ( ADC apparent diffusion coefficient ) values and the Ki-67 labeling index for luminal-type (estrogen receptor-positive) breast cancer not otherwise specified ( NOS not otherwise specified ) diagnosed by means of biopsy. MATERIALS AND METHODS The institutional review board approved this retrospective study, and the requirement for informed consent was waived. Between December 2009 and December 2012, 86 patients with 86 lesions with luminal-type invasive breast cancer NOS not otherwise specified underwent magnetic resonance imaging, including dynamic contrast material-enhanced imaging and diffusion-weighted imaging with b values of 0 and 1000 sec/mm(2). Conventional measurement of the minimum and mean ADC apparent diffusion coefficient s by placing regions of interest and histogram analysis of pixel-based ADC apparent diffusion coefficient data of the entire tumor were performed by two observers independently and correlated with the Ki-67 labeling index of surgical specimens. RESULTS For the interobserver reliability, interclass correlation coefficients for all parameters with the exception of the minimum ADC apparent diffusion coefficient exceeded 0.8, indicating almost perfect agreement. The minimum ADC apparent diffusion coefficient and mean ADC apparent diffusion coefficient and the 25th, 50th, and 75th percentiles of the histograms showed negative correlations with the Ki-67 labeling index (r = -0.49, -0.55, -0.54, -0.53, and -0.48, respectively). Receiver operating characteristic curve analysis for the differential diagnosis between the high-proliferation (Ki-67 ≥ 14; n = 44) and low-proliferation (Ki-67 < 14; n = 42) groups revealed that the most effective threshold for the mean ADC apparent diffusion coefficient was lower than 1097 × 10(-6) mm(2)/sec, with sensitivity and specificity of 82% and 71%, respectively. The area under the receiver operating characteristic curve (AUC) was 0.81 for the mean ADC apparent diffusion coefficient . There were no significant differences in the AUC among the parameters. CONCLUSION Considering convenience for routine practice, the authors suggest that the mean ADC apparent diffusion coefficient of the conventional method would be practical to use for estimating the Ki-67 labeling index.
This paper references
pression of ER , PgR , HER 1 , HER 2 , and response : a study of preoperative chemother
R Yerushalmi (2008)
10.2214/AJR.09.2355
Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI.
B. Dogan (2010)
Diffusion-weighted Imaging Improves the Diagnostic Accuracy of Conventional 3.0-T
R. Khouli (2010)
10.1186/1471-2407-11-341
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
Q. Romero (2011)
10.1007/s00330-013-2902-2
Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters
Naoko Mori (2013)
10.1259/bjr/79381464
Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer.
S. Choi (2012)
10.1016/J.EJRAD.2006.08.030
The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language?
D. Vanel (2007)
10.1016/J.YPAT.2011.11.057
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
B. A. Carter (2012)
Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009;253(2):341–351
W Bogner (2009)
10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2
Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas
T. Sugahara (1999)
10.1002/jmri.10140
Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging
Y. Guo (2002)
10.1002/jmri.22400
Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma
S. K. Jeh (2011)
10.1002/jmri.21884
Diffusion‐weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors
S. Kim (2009)
10.1007/s00330-012-2403-8
Correlations between diffusion-weighted imaging and breast cancer biomarkers
L. Martincich (2012)
10.1002/jmri.23635
Correlation of perfusion parameters on dynamic contrast‐enhanced MRI with prognostic factors and subtypes of breast cancers
H. R. Koo (2012)
10.1148/radiol.2532081718
Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?
W. Bogner (2009)
10.1093/ANNONC/MDM509
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
M. Colleoni (2008)
10.2307/2529310
The measurement of observer agreement for categorical data.
J. Landis (1977)
World Health Organization classification of tumor of the breast: IARC
Lakhani (2012)
10.1148/radiol.10091367
Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
Riham H Ei Khouli (2010)
10.1159/000346475
Correlation between Ki67 and Breast Cancer Prognosis
K. Kontzoglou (2013)
10.1148/radiol.2503081054
Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
T. Uematsu (2009)
sponsive breast cancer : results from Breast International Group Trial 198 comparing adjuvant tamoxifen with letrozole Neoadjuvant therapy for ER - positive breast cancers
M Colleoni (2012)
10.1093/annonc/mdt303
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch (2013)
10.1016/S1470-2045(09)70262-1
Ki67 in breast cancer: prognostic and predictive potential.
R. Yerushalmi (2010)
10.1200/JCO.2008.17.0829
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
G. Viale (2008)
10.1148/radiol.11101892
Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
M. Iima (2011)
10.2214/AJR.10.4258
Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.
S. Kul (2011)
10.1093/ANNONC/MDS305
Neoadjuvant therapy for ER-positive breast cancers.
M. Colleoni (2012)
10.1002/1097-0142(19930415)71:8<2507::AID-CNCR2820710813>3.0.CO;2-0
Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants
E. R. Fisher (1993)
10.1186/1472-6890-13-5
A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
Takayuki Kobayashi (2013)
Glioma grading by using histogram analysis of blood volume heterogeneity from MRderived cerebral blood volume maps. Radiology 2008;247(3):808–817
KE Emblem (2008)
10.1093/jnci/djp082
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
M. Cheang (2009)
10.1093/annonc/mdr304
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch (2011)
10.2214/AJR.08.2139
Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.
S. Partridge (2009)
10.1200/JCO.2008.18.1370
Supervised risk predictor of breast cancer based on intrinsic subtypes.
J. Parker (2009)
10.1002/jmri.23626
Diffusion‐weighted MRI as an adjunct to mammography in women under 50 years of age: An initial study
T. Kazama (2012)
10.1093/jnci/djr393
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.
M. Dowsett (2011)
Breast International Group (BIG
Group Collaborative (2005)
10.1148/radiol.2473070571
Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps.
K. Emblem (2008)
10.1200/JCO.2010.31.6950
Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.
M. Ellis (2011)
10.1056/NEJMOA052258
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
B. Thuerlimann (2005)



This paper is referenced by
10.18632/oncotarget.20406
Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 1: ADCmean
A. Surov (2017)
10.1002/jmri.25909
Diffusion‐weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2– breast cancers
Nita Amornsiripanitch (2018)
10.1007/s11604-020-00994-6
Correlation of contrast-enhanced ultrasound features with prognostic factors in invasive ductal carcinomas of the breast
J. Li (2020)
10.1007/s00330-019-06445-9
Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index
J. Lee (2019)
10.1002/jum.14663
Association Between Shear Wave Elastography of Virtual Touch Tissue Imaging Quantification Parameters and the Ki‐67 Proliferation Status in Luminal‐Type Breast Cancer
Y. Liu (2019)
10.1590/0100-3984.2016.0089
Can diffusion-weighted imaging add information in the evaluation of breast lesions considered suspicious on magnetic resonance imaging?
C. Guatelli (2017)
10.1016/j.crad.2017.11.019
Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
Z. Zhuang (2018)
10.1016/j.acra.2017.06.016
Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
H. Kawashima (2017)
10.1186/s13058-018-0991-1
Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis
A. Surov (2018)
10.1007/s00330-018-5439-6
Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy
M. Kozumi (2018)
10.1038/bjc.2017.26
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype
O. Catalano (2017)
10.1038/s41598-017-03122-z
Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer
Ming Fan (2017)
10.1016/j.ejrad.2015.08.009
Early-stage invasive ductal carcinoma: Association of tumor apparent diffusion coefficient values with axillary lymph node metastasis.
J. Y. Kim (2015)
10.1016/j.tranon.2017.05.004
Cone-beam Breast Computed Tomography: CT Density Does Not Reflect Proliferation Potential and Receptor Expression of Breast Carcinoma12
S. Wienbeck (2017)
10.5812/iranjradiol.33133
Additional Value of Diffusion-Weighted Imaging to Evaluate Prognostic Factors of Breast Cancer: Correlation with the Apparent Diffusion Coefficient
E. Park (2016)
10.1007/s00261-020-02795-x
Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma
Hainan Ren (2020)
10.1016/j.acra.2019.01.007
Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer.
N. Luo (2019)
10.1097/IGC.0000000000001259
A Predictor of Tumor Recurrence in Patients With Endometrial Carcinoma After Complete Resection of the Tumor: The Role of Pretreatment Apparent Diffusion Coefficient
Ryo Kuwahara (2018)
10.2214/AJR.15.15186
Supine Versus Standing Radiographs for Detecting Ischiofemoral Impingement: A Propensity Score-Matched Analysis.
Sunghoon Park (2016)
10.1371/journal.pone.0235278
Peritumor to tumor apparent diffusion coefficient ratio is associated with biologically more aggressive breast cancer features and correlates with the prognostication tools
H. Okuma (2020)
10.2463/mrms.mp.2016-0037
Diagnostic Performance of Diffusion Tensor Imaging with Readout-segmented Echo-planar Imaging for Invasive Breast Cancer: Correlation of ADC and FA with Pathological Prognostic Markers
K. Yamaguchi (2017)
10.1016/j.mri.2018.08.017
Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
S. Kim (2018)
10.1016/J.EUO.2018.12.006
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review.
A. Surov (2019)
10.1097/RLI.0000000000000166
The Changing World of Breast Cancer
C. Kuhl (2015)
10.18632/oncotarget.24006
Associations between apparent diffusion coefficient (ADC) and KI 67 in different tumors: a meta-analysis. Part 2: ADCmin
A. Surov (2018)
10.1002/jmri.25348
Dynamic contrast‐enhanced and diffusion‐weighted MRI of estrogen receptor‐positive invasive breast cancers: Associations between quantitative MR parameters and Ki‐67 proliferation status
Jong Ki Shin (2017)
10.1155/2015/613831
Contrast-Enhanced Ultrasonography Features of Breast Malignancies with Different Sizes: Correlation with Prognostic Factors
L. Zhao (2015)
10.1148/radiol.15141625
Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.
K. Sun (2015)
10.3892/ol.2018.9312
Intravoxel incoherent motion magnetic resonance imaging for breast cancer: A comparison with benign lesions and evaluation of heterogeneity in different tumor regions with prognostic factors and molecular classification
M. Zhao (2018)
10.3389/fonc.2020.611571
Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient as a Quantitative Imaging Biomarker for Assessing the Level of Tumor-Infiltrating Lymphocytes: Value in Molecular Subtypes of Breast Cancer
Wen-jie Tang (2020)
10.1007/s00330-017-4786-z
Primary and metastatic ovarian cancer: Characterization by 3.0T diffusion-weighted MRI
A. Lindgren (2017)
10.1097/PSN.0000000000000128
The Changing World of Breast Cancer: A Radiologist's Perspective
C. Kuhl (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar